All Stories

  1. Novel Vesicular Bilosomal Delivery Systems for Dermal/Transdermal Applications
  2. Demonstration of Advanced Data Mining Tools for Optimization of Pellets Employing Modified Extrusion-pelletization Technique
  3. Novel therapeutic approaches for targeting TB and HIV reservoirs prevailing in lungs
  4. Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB
  5. Approaches for CNS delivery of drugs – nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment
  6. Antibacterial Properties of Graphene Based Nanomaterials: An Emphasis on Molecular Mechanisms, Surface Engineering and Size of Sheets
  7. Preparation and evaluation of nanoparticles loaded ophthalmicin situgel
  8. Formulation and evaluation of floating tablet of H2-receptor antagonist
  9. Fumarate metabolism and ATP production in Pseudomonas fluorescens exposed to nitrosative stress
  10. Liposome-Entrapped Antibiotics
  11. Co-administration of aqueous ginseng extract with tobramycin stimulates the pro-inflammatory response and promotes the killing of Pseudomonas aeruginosa in the lungs of infected rats
  12. Hydrogen peroxide stress provokes a metabolic reprogramming in Pseudomonas fluorescens: Enhanced production of pyruvate
  13. Liposomal antibiotics for the treatment of infectious diseases
  14. Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity
  15. Efficacy and Safety of Liposomal Clarithromycin and Its Effect on Pseudomonas aeruginosa Virulence Factors
  16. Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems
  17. Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection
  18. Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model
  19. Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis
  20. Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa
  21. Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, and eradicates biofilms of Pseudomonas aeruginosa
  22. Treatment of ricin A-chain-induced hepatotoxicity with liposome-encapsulated N-acetylcysteine
  23. Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells
  24. Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes
  25. The effect of aminoglycoside antibiotics on the thermodynamic properties of liposomal vesicles
  26. Role of nanocarrier systems in cancer nanotherapy
  27. Characterization of the interaction between liposomal formulations andPseudomonas aeruginosa
  28. The effect of aminoglycoside antibiotics on the thermodynamic properties of liposomal vesicles
  29. Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis
  30. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa
  31. Bismuth–thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa
  32. Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents
  33. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa
  34. Liposomes as a carrier for gentamicin delivery: Development and evaluation of the physicochemical properties
  35. Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin
  36. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains
  37. Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting
  38. Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries
  39. Importance of divalent cations in nanolipoplex gene delivery
  40. Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia
  41. Mechanism of Enhanced Activity of Liposome-Entrapped Aminoglycosides against Resistant Strains of Pseudomonas aeruginosa
  42. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time–kill study
  43. The Role of Liposomal Antioxidants in Oxidative Stress
  44. Preparation and characterization of dehydration–rehydration vesicles loaded with aminoglycoside and macrolide antibiotics
  45. Recent trends in the lipid-based nanoencapsulation of antioxidants and their role in foods
  46. Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients
  47. Antimicrobial efficacy of a new antibiotic-loaded poly(hydroxybutyric-co-hydroxyvaleric acid) controlled release system
  48. The Effect of Different Lipid Components on the In Vitro Stability and Release Kinetics of Liposome Formulations
  49. Disposition of 3 H-Cholesteryl Ether Labeled Liposomes Following Intravenous Administration to Mice: Comparison with an Encapsulated 14 C-Inulin as Aqueous Phase Marker
  50. Short-Term Repeated-Dose Toxicity Profile of Archaeosomes Administered to Mice via Intravenous and Oral Routes
  51. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection
  52. Pseudomonas aeruginosa-induced lung injury: role of oxidative stress
  53. SAFETY OF ARCHAEOSOME ADJUVANTS EVALUATED IN A MOUSE MODEL*
  54. Incorporation rates, stabilities, cytotoxicities and release of liposomal tetracycline and doxycycline in human serum [In Process Citation]
  55. Serotyping clinical isolates of Pseudomonas aeruginosa in relation to infection site antibiotic susceptibility and beta-lactamase production
  56. Preparation, properties and the effects of amikacin, netilmicin and tobramycin in free and liposomal formulations on Gram-negative and Gram-positive bacteria
  57. Platelet-induced vasomotion of isolated canine coronary artery in the presence of halothane or isoflurane
  58. Mechanism of Halothane Attenuation of Isometric Tension Induced by Serotonin in Isolated Canine Coronary Artery Rings
  59. Artificial Implants – New Developments and Associated Problems